Ekso Bionics Holdings (EKSO) Total Current Liabilities (2016 - 2026)
Ekso Bionics Holdings has reported Total Current Liabilities over the past 13 years, most recently at $8.6 million for Q4 2025.
- On a quarterly basis, Total Current Liabilities rose 14.58% to $8.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $8.6 million, a 14.58% increase, with the full-year FY2025 number at $8.6 million, up 14.58% from a year prior.
- Total Current Liabilities reached $8.6 million in Q4 2025 per EKSO's latest filing, down from $8.9 million in the prior quarter.
- The five-year high for Total Current Liabilities was $10.1 million in Q2 2023, with the low at $4.7 million in Q3 2021.
- The 5-year median for Total Current Liabilities is $7.6 million (2024), against an average of $7.4 million.
- Peak YoY movement for Total Current Liabilities: surged 110.19% in 2023, then fell 23.94% in 2024.
- Tracing EKSO's Total Current Liabilities over 5 years: stood at $6.9 million in 2021, then surged by 34.22% to $9.2 million in 2022, then fell by 11.78% to $8.1 million in 2023, then decreased by 7.15% to $7.5 million in 2024, then grew by 14.58% to $8.6 million in 2025.
- According to Business Quant data, Total Current Liabilities over the past three periods came in at $8.6 million, $8.9 million, and $6.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.